Ilia I. Ouspenski

Array ( [id] => 92512 [patent_doc_number] => 07737260 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-15 [patent_title] => 'Protein complex using an immunoglobulin fragment and method for the preparation thereof' [patent_app_type] => utility [patent_app_number] => 10/535232 [patent_app_country] => US [patent_app_date] => 2004-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 19353 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/737/07737260.pdf [firstpage_image] =>[orig_patent_app_number] => 10535232 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 366810 [patent_doc_number] => 07479544 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-01-20 [patent_title] => 'Anti-PRO87299 antibodies' [patent_app_type] => utility [patent_app_number] => 10/987663 [patent_app_country] => US [patent_app_date] => 2004-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 43488 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/479/07479544.pdf [firstpage_image] =>[orig_patent_app_number] => 10987663 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6957944 [patent_doc_number] => 20050214314 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-29 [patent_title] => 'Human cytokine receptor' [patent_app_type] => utility [patent_app_number] => 10/981998 [patent_app_country] => US [patent_app_date] => 2004-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 61312 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20050214314.pdf [firstpage_image] =>[orig_patent_app_number] => 10981998 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6940001 [patent_doc_number] => 20050113564 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-26 [patent_title] => 'Chimeric receptors with 4-1BB stimulatory signaling domain' [patent_app_type] => utility [patent_app_number] => 10/981352 [patent_app_country] => US [patent_app_date] => 2004-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 14573 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20050113564.pdf [firstpage_image] =>[orig_patent_app_number] => 10981352 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5258669 [patent_doc_number] => 20070212301 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-13 [patent_title] => 'Monkey Immunoglobulin Sequences' [patent_app_type] => utility [patent_app_number] => 10/578580 [patent_app_country] => US [patent_app_date] => 2004-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 15658 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20070212301.pdf [firstpage_image] =>[orig_patent_app_number] => 10578580 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6957943 [patent_doc_number] => 20050214313 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-29 [patent_title] => 'Soluble CTLA4 mutant molecules and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/980742 [patent_app_country] => US [patent_app_date] => 2004-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 13575 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20050214313.pdf [firstpage_image] =>[orig_patent_app_number] => 10980742 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6917683 [patent_doc_number] => 20050095244 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-05 [patent_title] => 'Fully human antibodies against human 4-1BB' [patent_app_type] => utility [patent_app_number] => 10/961567 [patent_app_country] => US [patent_app_date] => 2004-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 11862 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0095/20050095244.pdf [firstpage_image] =>[orig_patent_app_number] => 10961567 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5738991 [patent_doc_number] => 20060009382 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-12 [patent_title] => 'Use of a CD28 binding pharmaceutical substance for making a pharmaceutical composition with dose-dependent effect' [patent_app_type] => utility [patent_app_number] => 10/946836 [patent_app_country] => US [patent_app_date] => 2004-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 7661 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20060009382.pdf [firstpage_image] =>[orig_patent_app_number] => 10946836 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7011610 [patent_doc_number] => 20050065326 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-24 [patent_title] => 'Antibodies that specifically bind to TR2' [patent_app_type] => utility [patent_app_number] => 10/939359 [patent_app_country] => US [patent_app_date] => 2004-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 68798 [patent_no_of_claims] => 76 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20050065326.pdf [firstpage_image] =>[orig_patent_app_number] => 10939359 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13339 [patent_doc_number] => 07803553 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-09-28 [patent_title] => 'Methods of use of antibodies which recognize a protease cleavage site of an LAP fragment of TGF-β' [patent_app_type] => utility [patent_app_number] => 10/570606 [patent_app_country] => US [patent_app_date] => 2004-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 11028 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/803/07803553.pdf [firstpage_image] =>[orig_patent_app_number] => 10570606 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6971724 [patent_doc_number] => 20050037434 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-17 [patent_title] => 'Monoclonal antibody against costimulatory molecule M150 and a process for preparation thereof' [patent_app_type] => utility [patent_app_number] => 10/917938 [patent_app_country] => US [patent_app_date] => 2004-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4056 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20050037434.pdf [firstpage_image] =>[orig_patent_app_number] => 10917938 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7176121 [patent_doc_number] => 20050123539 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-09 [patent_title] => 'Methods for treating cardiovascular disease using a soluble CTLA4 molecule' [patent_app_type] => utility [patent_app_number] => 10/910531 [patent_app_country] => US [patent_app_date] => 2004-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 103 [patent_figures_cnt] => 103 [patent_no_of_words] => 51181 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20050123539.pdf [firstpage_image] =>[orig_patent_app_number] => 10910531 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5100760 [patent_doc_number] => 20070184022 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-09 [patent_title] => 'Microsome vaccine' [patent_app_type] => utility [patent_app_number] => 10/566823 [patent_app_country] => US [patent_app_date] => 2004-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 18699 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0184/20070184022.pdf [firstpage_image] =>[orig_patent_app_number] => 10566823 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5677386 [patent_doc_number] => 20060182741 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-17 [patent_title] => 'Use of adcc-optimized antibodies for treating weak patients' [patent_app_type] => utility [patent_app_number] => 10/566358 [patent_app_country] => US [patent_app_date] => 2004-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6890 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20060182741.pdf [firstpage_image] =>[orig_patent_app_number] => 10566358 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5921337 [patent_doc_number] => 20060240005 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-26 [patent_title] => 'Methods and compositions for increasing the efficiency of therapeutic antibodies using alloreactive natural killer cells' [patent_app_type] => utility [patent_app_number] => 10/565761 [patent_app_country] => US [patent_app_date] => 2004-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8331 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0240/20060240005.pdf [firstpage_image] =>[orig_patent_app_number] => 10565761 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4988130 [patent_doc_number] => 20070154469 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-05 [patent_title] => 'IGM production by transformed cells and methods of quantifying said IgM production' [patent_app_type] => utility [patent_app_number] => 10/564665 [patent_app_country] => US [patent_app_date] => 2004-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 22066 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0154/20070154469.pdf [firstpage_image] =>[orig_patent_app_number] => 10564665 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 64331 [patent_doc_number] => 07759464 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-07-20 [patent_title] => 'N-glycosylated antibody' [patent_app_type] => utility [patent_app_number] => 11/571983 [patent_app_country] => US [patent_app_date] => 2004-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 6503 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/759/07759464.pdf [firstpage_image] =>[orig_patent_app_number] => 11571983 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7127307 [patent_doc_number] => 20050059051 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-17 [patent_title] => 'B7-H1, a novel immunoregulatory molecule' [patent_app_type] => utility [patent_app_number] => 10/890789 [patent_app_country] => US [patent_app_date] => 2004-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 12394 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20050059051.pdf [firstpage_image] =>[orig_patent_app_number] => 10890789 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7345430 [patent_doc_number] => 20040247594 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-09 [patent_title] => 'Use of cd28-specific monoclonal antibodies for stimulating blood cells that lack cd28' [patent_app_type] => new [patent_app_number] => 10/399056 [patent_app_country] => US [patent_app_date] => 2004-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 7860 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20040247594.pdf [firstpage_image] =>[orig_patent_app_number] => 10399056 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5894389 [patent_doc_number] => 20060002928 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-05 [patent_title] => 'Methods and molecules for modulating an immune response' [patent_app_type] => utility [patent_app_number] => 10/881661 [patent_app_country] => US [patent_app_date] => 2004-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 22020 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20060002928.pdf [firstpage_image] =>[orig_patent_app_number] => 10881661 [rel_patent_id] =>[rel_patent_doc_number] =>)